Abstract
Purpose
The aim of this study was to assess the clinical significance of N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in the differentiation of patients with cardiac and reflex syncope.
Methods
The study included a group of 100 patients (56 women, 44 men), aged 18–77 years (mean 52.6 ± 16.7), with a history of reflex (group I) or cardiac syncope (group II). Diagnosis of syncope was performed according to the European Society of Cardiology (ESC) guidelines. In all patients, the concentration of NT-proBNP was measured.
Results
The assessment of NT-proBNP concentrations showed significantly higher concentrations in group II than in group I (448.7 ± 212.2 vs. 68.2 ± 64.1 pg/ml, P < 0.0001). The receiver operating characteristic (ROC) curve analysis revealed that the concentration of NT-proBNP at 210.5 pg/ml may be a useful cut-off point which allows the prediction of cardiac syncope with 98 % specificity, 94 % sensitivity, and 94 % negative predictive value. In patients with cardiac arrhythmias and conduction abnormalities, the concentrations of NT-proBNP were higher in comparison to those without such disorders.
Conclusions
The concentration of NT-proBNP is useful in the diagnosis of syncope and may initially guide the diagnostic process. The NT-proBNP value exceeding 200 pg/ml seems to be the most rational in determining cardiac syncope.
Similar content being viewed by others
References
Moya, A., Sutton, R., Ammirati, F., Blanc, J. J., Brignole, M., Dahm, J. B., et al. (2009). Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal, 30(21), 2631–2671.
Huff, J. S., Decker, W. W., Quinn, J. V., Perron, A. D., Napoli, A. M., Peeters, S., et al. (2007). Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Annals of Emergency Medicine, 49(4), 431–444.
Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., et al. (2002). Incidence and prognosis of syncope. New England Journal of Medicine, 347(12), 878–885.
Rademaker, M. T., & Richards, A. M. (2005). Cardiac natriuretic peptides for cardiac health. Clinical Science, 108(1), 23–36.
Fitzpatrick, A. P., Theodorakis, G., Vardas, P., & Sutton, R. (1991). Methodology of head-up tilt testing in patients with unexplained syncope. Journal of the American College of Cardiology, 17(1), 125–130.
Crawford, M. H., Bernstein, S. J., Deedwania, P. C., DiMarco, J. P., Ferrick, K. J., Garson, A., et al. (1999). ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology. Journal of the American College of Cardiology, 34(3), 912–948.
Cheitlin, M. D., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davis, J. L., et al. (2003). ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Journal of the American College of Cardiology, 42(5), 954–970.
Freitag, M. H., Larson, M. G., Levy, D., Benjamin, E. J., Wang, T. J., Leip, E. P., et al. (2003). Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension, 41(4), 978–983.
Lellouche, N., Berthier, R., Mekontso-Dessap, A., Braconnier, F., Monin, J. L., Duval, A. M., et al. (2005). Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. The American Journal of Cardiology, 95(11), 1380–1382.
Seino, Y., Ogawa, A., Yamashita, T., Fukushima, M., Ogata, K. I., Fukumoto, H., & Takano, T. (2004). Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. European Journal of Heart Failure, 6(3), 295–300.
Stryjewski, P. J., Nessler, B., Cubera, K., & Nessler, J. (2013). Natriuretic peptides. History of discovery, chemical structure, mechanism of action and the removal routes. Basis of diagnostic and therapeutic use. Przegla̧d Lekarski, 70(7), 463–467.
Stryjewski, P. J., Nessler, B., Matusik, P., Badacz, L., Nowak, J., & Nessler, J. (2014). Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology. Przeglad Lekarski, 71(1), 33–35.
Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., et al. (2008). Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal, 29(18), 2276–2315.
Lim, P., Monin, J. L., Monchi, M., Garot, J., Pasquet, A., Hittinger, L., et al. (2004). Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. European Heart Journal, 25(22), 2048–2053.
McMurray, J. J., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., et al. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33(14), 1787–1847.
N-terminal pro B-type natriuretic peptide. Cobas. Resource document. Roche Canada. http://www.rochecanada.com/fmfiles/re7234008/package_inserts/04842464190-ProBNPII-V8-English.pdf
Tanimoto, K., Yukiiri, K., Mizushige, K., Takagi, Y., Masugata, H., Shinomiya, K., et al. (2004). Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. The American Journal of Cardiology, 93(2), 228–230.
Pfister, R., Diedrichs, H., Larbig, R., Erdmann, E., & Schneider, C. A. (2009). NT-pro-BNP for differential diagnosis in patients with syncope. International Journal of Cardiology, 133(1), 51–54.
Pfister, R., Hagemeister, J., Esser, S., Hellmich, M., Erdmann, E., & Schneider, C. A. (2012). NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. International Journal of Cardiology, 155(2), 268–272.
Kapoor, W. N., Karpf, M., Wieand, S., Peterson, J. R., & Levey, G. S. (1983). A prospective evaluation and follow-up of patients with syncope. New England Journal of Medicine, 309(4), 197–204.
Sarasin, F. P., Louis-Simonet, M., Carballo, D., Slama, S., Rajeswaran, A., Metzger, J. T., et al. (2001). Prospective evaluation of patients with syncope: a population-based study. The American Journal of Medicine, 111(3), 177–184.
Reed, M. J., Newby, D. E., Coull, A. J., Prescott, R. J., Jacques, K. G., & Gray, A. J. (2010). The ROSE (risk stratification of syncope in the emergency department) study. Journal of the American College of Cardiology, 55(8), 713–721.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stryjewski, P.J., Nessler, B., Kuczaj, A. et al. The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations. J Interv Card Electrophysiol 41, 1–8 (2014). https://doi.org/10.1007/s10840-014-9923-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-014-9923-x